Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone vs Metformin in Newly Diagnosed Type 2 Diabetes
NCT02526615Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Oct 2000
- Primary completion
- Dec 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by Turku University Hospital. Started Oct 2000; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02526615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526615.